Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.32 USD | +2.37% | -0.23% | +33.02% |
Mar. 20 | Canaccord Genuity Adjusts Price Target on Tenaya Therapeutics to $18 From $19, Maintains Buy Rating | MT |
Mar. 19 | North American Morning Briefing : Stock Futures -2- | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+33.02% | 331M | |
+2.06% | 42.59B | |
+7.33% | 40.65B | |
+49.11% | 40.57B | |
-11.96% | 26.77B | |
+8.96% | 24.81B | |
-24.01% | 18.17B | |
+27.41% | 12.05B | |
-3.09% | 11.7B | |
+7.04% | 11.1B |
- Stock Market
- Equities
- TNYA Stock
- News Tenaya Therapeutics, Inc.
- Tenaya Therapeutics Jumps in Pre-Market Trading; Director David Goeddel Purchases 185,151 Shares